$NVCR
NovoCure Limited Ordinary Shares
XNAS•Health Care•Surgical & Medical Instruments & Apparatus
Why is NVCR down today? It is at $17.77 (-2.36%), and our scanner flagged it 104 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment NVCR spikes, and full due diligence on NVCR — key stats, earnings, dilution and insider activity. Free.
Get free $NVCR alerts the moment volume spikes
Our scanner flagged $NVCR 104 times in the last 30 days. Create a free account to track $NVCR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $17.77
- Change today
- -2.36%
- Previous close
- $18.20
- 52-week range
- $9.82 – $21.45
- Market cap
- $2.01B
- Shares outstanding
- 116.4M SEC · as of 2026-07-17 · 34d
- Institutional own.
- 99.22%
- Total held
- 100.0%
- Short interest
- 10.1M ▼ -12% vs prior · as of 2026-07-31
- Days to cover
- 4.9d
- Avg daily volume
- 1.7M
- Sector
- Health Care
- Industry
- Surgical & Medical Instruments & Apparatus
- Exchange
- XNAS
- 5m
- 0.3x
- 15m
- 0.4x
- 1h
- 0.7x
- 1D
- 0.2x
Get free NVCR + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $NVCR down today?
Here is the latest on NVCR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NVCR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystNovocure Reports Second Quarter 2026 Financial ResultsReported Total net revenues for the quarter were $183.6 million, an increase of 16% compared to the same period in 2025. This increase was primarily driven by active patient growth globally.Reported $2.8 million in net revenue recognized from one-time benefits in the U.S., Germany and France.Reported Recognized revenue from Optune Lua in the quarter was $5.4 million. The U.S., Germany and Japan contributed $1.9 million, $1.7 million and $1.8 million, respectively., from an SEC filing. Read it →Latest filing144Notice of proposed insider sale (144)Jul 23, 2026 · 28 days agoAnalyst data via Nasdaq. Not investment advice.
Insiders
Insiders buying12 buys, 8 sells last 3 months (24/33 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Danziger Asaf Director | Acquired (grant/award) | +268 | added <0.1% | 417K | $3K at $11.15 | Jun 30, 26 |
Ben Arye Barak Officer | Acquired (grant/award) | +1K | added 0.5% | 244K | $14K at $11.15 | Jun 30, 26 |
Leonard Frank X Officer | Acquired (grant/award) | +2K | added 0.4% | 461K | $21K at $11.15 | Jun 30, 26 |
Puri Michal Nath Officer | Acquired (grant/award) | +2K | added 0.9% | 203K | $21K at $11.15 | Jun 30, 26 |
Leonard Frank X Officer | Sold (automatic/other) | -34K 0.03% of company | sold 6.9% | 460K | $615K at $17.93 | Jun 4, 26 |
Vernon W Anthony Director | Acquired (grant/award) | +12K | added 5.9% | 209K | n/a | Jun 3, 26 |
Madden Martin J. Director | Acquired (grant/award) | +12K | added 62% | 30K | n/a | Jun 3, 26 |
Hung David Director | Acquired (grant/award) | +12K | added 57% | 32K | n/a | Jun 3, 26 |
Hilleman Jeryl L Director | Acquired (grant/award) | +12K | added 84% | 25K | n/a | Jun 3, 26 |
Scannell Timothy J Director | Acquired (grant/award) | +12K | added 81% | 26K | n/a | Jun 3, 26 |
Ocean Allyson J Director | Acquired (grant/award) | +12K | added 100% | 23K | n/a | Jun 3, 26 |
Stafford Kristin Director | Acquired (grant/award) | +12K | added 100% | 23K | n/a | Jun 3, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
$NVCR Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$NVCR Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to NVCR
Comparable names in surgical & medical instruments & apparatus, closest in size first.
NVCR stock FAQ
Why is $NVCR down today?
Here is the latest on NVCR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NVCR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the NVCR stock price today?
NVCR last traded at $17.77, down 2.36% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live NVCR alerts?
The NVCR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged NVCR 104 times in the last 30 days.
What exchange is NVCR on?
NVCR (NovoCure Limited Ordinary Shares) trades on XNAS, with a market cap of about $2.01B in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.
Is NVCR good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge NVCR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.